Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date02 Mar 2005 |
以输尿管结石患者为研究对象的优克龙片双盲平行组间比较临床试验
[Translation] A double-blind parallel-group comparative clinical trial of Uroclone tablets in patients with ureteral calculi
以输尿管结石患者为研究对象,使用优克龙片剂或者安慰剂进行最长3周的治疗,以排石率为指标,验证优克龙片剂相对于安慰剂的优效性。
[Translation] Patients with ureteral stones were selected as research subjects. They were treated with Ureterone tablets or placebo for up to 3 weeks. The stone excretion rate was used as an indicator to verify the superiority of Ureterone tablets over placebo.
100 Clinical Results associated with Simico Medical Technology Development (Beijing) Co., Ltd.
0 Patents (Medical) associated with Simico Medical Technology Development (Beijing) Co., Ltd.
100 Deals associated with Simico Medical Technology Development (Beijing) Co., Ltd.
100 Translational Medicine associated with Simico Medical Technology Development (Beijing) Co., Ltd.